NEOGENOMICS INC Insider Trading for November 2019

FREE EMAIL WATCHDOG

Get free email notifications about insider trading in NEOGENOMICS INC.

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview


Overview of insider trading in NEOGENOMICS INC for November 2019.

<<< Back to the month list

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Nov 22 2019NEONEOGENOMICS INCJONES STEVEN CDirectorGiftG24.5350,0001,226,500195,234245.2 K to 195.2 K (-20.39 %)
Nov 22 2019NEONEOGENOMICS INCJONES STEVEN CDirectorSellS24.2723,162562,1421,525,0001.5 M to 1.5 M (-1.50 %)
Nov 22 2019NEONEOGENOMICS INCJONES STEVEN CDirectorSellS24.35128,0683,118,4561,548,1621.7 M to 1.5 M (-7.64 %)
Nov 21 2019NEONEOGENOMICS INCVAN OORT DOUGLAS MChairman and CEOSellS24.08187,5004,515,0000187.5 K to 0 (-100.00 %)
Nov 18 2019NEONEOGENOMICS INCBALLIET JENNIFERVP and Chief Cultur ...Option ExerciseM8.031661,33348,334
Nov 18 2019NEONEOGENOMICS INCBALLIET JENNIFERVP and Chief Cultur ...Option ExerciseM7.526,66750,13620,000
Nov 18 2019NEONEOGENOMICS INCBALLIET JENNIFERVP and Chief Cultur ...SellS23.456,833160,23422,86229.7 K to 22.9 K (-23.01 %)
Nov 18 2019NEONEOGENOMICS INCBALLIET JENNIFERVP and Chief Cultur ...BuyM8.031661,33329,69529.5 K to 29.7 K (+0.56 %)
Nov 18 2019NEONEOGENOMICS INCBALLIET JENNIFERVP and Chief Cultur ...BuyM7.526,66750,13629,52922.9 K to 29.5 K (+29.16 %)
Nov 14 2019NEONEOGENOMICS INCCARDOZA GEORGEPresident, Pharma S ...Option ExerciseM7.1544,444317,775100,000
Nov 14 2019NEONEOGENOMICS INCCARDOZA GEORGEPresident, Pharma S ...SellS23.1519,444450,129325,831345.3 K to 325.8 K (-5.63 %)
Nov 14 2019NEONEOGENOMICS INCCARDOZA GEORGEPresident, Pharma S ...BuyM7.1544,444317,775345,275300.8 K to 345.3 K (+14.77 %)
Nov 13 2019NEONEOGENOMICS INCVAN OORT DOUGLAS MChairman and CEOOption ExerciseM7.15472,5273,378,5680
Nov 13 2019NEONEOGENOMICS INCVAN OORT DOUGLAS MChairman and CEOPayment of ExerciseF0.00205,63502,277,3912.5 M to 2.3 M (-8.28 %)
Nov 13 2019NEONEOGENOMICS INCVAN OORT DOUGLAS MChairman and CEOBuyM7.15472,5273,378,5682,483,0262 M to 2.5 M (+23.50 %)
Nov 13 2019NEONEOGENOMICS INCVAN OORT DOUGLAS MChairman and CEOPayment of ExerciseF0.006,09002,010,4992 M to 2 M (-0.30 %)
Nov 08 2019NEONEOGENOMICS INCCARDOZA GEORGEPresident, Pharma S ...Option ExerciseM7.1555,556397,225144,444
Nov 08 2019NEONEOGENOMICS INCCARDOZA GEORGEPresident, Pharma S ...SellS22.804,00091,200300,831304.8 K to 300.8 K (-1.31 %)
Nov 08 2019NEONEOGENOMICS INCCARDOZA GEORGEPresident, Pharma S ...SellS22.8251,5561,176,508304,831356.4 K to 304.8 K (-14.47 %)
Nov 08 2019NEONEOGENOMICS INCCARDOZA GEORGEPresident, Pharma S ...BuyM7.1555,556397,225356,387300.8 K to 356.4 K (+18.47 %)
Nov 04 2019NEONEOGENOMICS INCJohnson Kevin CDirectorOption ExerciseM11.603,01734,9970
Nov 04 2019NEONEOGENOMICS INCJohnson Kevin CDirectorOption ExerciseM7.276,66648,4623,334
Nov 04 2019NEONEOGENOMICS INCJohnson Kevin CDirectorOption ExerciseM9.118,33375,9140
Nov 04 2019NEONEOGENOMICS INCJohnson Kevin CDirectorOption ExerciseM4.786,66731,8680
Nov 04 2019NEONEOGENOMICS INCJohnson Kevin CDirectorBuyM11.603,01734,99752,96850 K to 53 K (+6.04 %)
Nov 04 2019NEONEOGENOMICS INCJohnson Kevin CDirectorBuyM7.276,66648,46249,95143.3 K to 50 K (+15.40 %)
Nov 04 2019NEONEOGENOMICS INCJohnson Kevin CDirectorBuyM9.118,33375,91443,28535 K to 43.3 K (+23.84 %)
Nov 04 2019NEONEOGENOMICS INCJohnson Kevin CDirectorBuyM4.786,66731,86834,95228.3 K to 35 K (+23.57 %)
Nov 04 2019NEONEOGENOMICS INCSHOVLIN ROBERT J.President, Clinical ...Option ExerciseM8.0396,166772,213192,334
Nov 04 2019NEONEOGENOMICS INCSHOVLIN ROBERT J.President, Clinical ...SellS22.7435,801814,115145,640181.4 K to 145.6 K (-19.73 %)
Nov 04 2019NEONEOGENOMICS INCSHOVLIN ROBERT J.President, Clinical ...SellS23.1170,4731,628,631181,441251.9 K to 181.4 K (-27.98 %)
Nov 04 2019NEONEOGENOMICS INCSHOVLIN ROBERT J.President, Clinical ...BuyM8.0396,166772,213251,914155.7 K to 251.9 K (+61.74 %)

Contact us | Follow us on Twitter